Lavipharm S.A. (LAVI.AT)

EUR 0.76

(-1.82%)

Operating Expenses Summary of Lavipharm S.A.

Lavipharm S.A.'s latest annual operating expenses in 2023 was 18.13 Million EUR , up 32.49% from previous year.
Lavipharm S.A.'s latest quarterly operating expenses in 2024 Q2 was 9.34 Million EUR , down -6.94% from previous quarter.
Lavipharm S.A. reported a annual operating expenses of 13.68 Million EUR in annual operating expenses 2022, down -9.3% from previous year.
Lavipharm S.A. reported a annual operating expenses of 15.09 Million EUR in annual operating expenses 2021, up 14.83% from previous year.
Lavipharm S.A. reported a quarterly operating expenses of 18.13 Million EUR for 2023 FY, up 32.49% from previous quarter.
Lavipharm S.A. reported a quarterly operating expenses of 8.09 Million EUR for 2023 Q2, down -2.72% from previous quarter.

Annual Operating Expenses Chart of Lavipharm S.A. (2023 - 2016)

Historical Annual Operating Expenses of Lavipharm S.A. (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	18.13 Million EUR	32.49%
2022	13.68 Million EUR	-9.3%
2021	15.09 Million EUR	14.83%
2020	13.14 Million EUR	-6.61%
2019	14.07 Million EUR	-6.91%
2018	15.11 Million EUR	15.78%
2017	13.05 Million EUR	-24.02%
2016	17.18 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	9.34 Million EUR	-6.94%
2023 FY	18.13 Million EUR	32.49%
2023 Q2	8.09 Million EUR	-2.72%
2023 Q4	10.03 Million EUR	24.0%
2022 Q2	6.91 Million EUR	-14.83%
2022 FY	13.68 Million EUR	-9.3%
2022 Q4	8.32 Million EUR	20.28%
2021 Q2	6.96 Million EUR	1.4%
2021 FY	15.09 Million EUR	14.83%
2021 Q4	8.12 Million EUR	16.61%
2020 FY	13.14 Million EUR	-6.61%
2020 Q4	6.87 Million EUR	10.82%
2020 Q2	6.2 Million EUR	-7.61%
2019 FY	14.07 Million EUR	-6.91%
2019 Q4	6.71 Million EUR	0.0%
2018 FY	15.11 Million EUR	15.78%
2017 FY	13.05 Million EUR	-24.02%
2016 FY	17.18 Million EUR	0.0%

Peer Operating Expenses Comparison of Lavipharm S.A.

Name	Operating Expenses	Operating Expenses Difference